IA-14069
/ ILAb
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
May 20, 2025
MAD Study of IA-14069
(clinicaltrials.gov)
- P1 | N=75 | Recruiting | Sponsor: ILAb Co., Ltd. | Trial completion date: Dec 2024 ➔ Feb 2026 | Trial primary completion date: Sep 2024 ➔ Nov 2025
Trial completion date • Trial primary completion date • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
October 13, 2023
MAD Study of IA-14069
(clinicaltrials.gov)
- P1 | N=75 | Recruiting | Sponsor: ILAb Co., Ltd. | Trial completion date: Nov 2023 ➔ Dec 2024 | Trial primary completion date: Apr 2023 ➔ Sep 2024
Trial completion date • Trial primary completion date • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
January 04, 2023
SAD Study of IA-14069
(clinicaltrials.gov)
- P1 | N=40 | Completed | Sponsor: ILAb Co., Ltd. | Recruiting ➔ Completed | Trial completion date: May 2023 ➔ Sep 2022
Trial completion • Trial completion date
November 08, 2022
MAD Study of IA-14069
(clinicaltrials.gov)
- P1 | N=75 | Recruiting | Sponsor: ILAb Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
September 09, 2022
MAD Study of IA-14069
(clinicaltrials.gov)
- P1 | N=75 | Not yet recruiting | Sponsor: ILAb Co., Ltd.
New P1 trial • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
September 09, 2022
SAD Study of IA-14069
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: ILAb Co., Ltd. | N=32 ➔ 48 | Trial primary completion date: Sep 2022 ➔ Dec 2022
Enrollment change • Trial primary completion date
1 to 6
Of
6
Go to page
1